(c) 2024 PillSync.com

fluoxetine fluoxetine hydrochloride capsule

1 INDICATIONS AND USAGE Fluoxetine capsules are indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder [see Clinical Studies (14.1) ] . Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD) [see Clinical Studies (14.2) ] . Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa [see Clinical Studies (14.3) ] . Acute treatment of Panic Disorder, with or without agoraphobia [see Clinical Studies (14.4) ] . Fluoxetine capsules and Olanzapine in Combination are indicated for the treatment of: Acute treatment of depressive episodes associated with Bipolar I Disorder. Treatment resistant depression (Major Depressive Disorder in patients, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode). Fluoxetine capsules monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression. When using fluoxetine capsules and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax Ā® . Fluoxetine capsules are a selective serotonin reuptake inhibitor indicated for: Acute and maintenance treatment of Major Depressive Disorder (MDD) ( 1 ) Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) ( 1 ) Acute and maintenance treatment of Bulimia Nervosa ( 1 ) Acute treatment of Panic Disorder, with or without agoraphobia ( 1 ) Fluoxetine capsules and olanzapine in combination for treatment of: Acute Depressive Episodes Associated with Bipolar I Disorder ( 1 ) Treatment Resistant Depression ( 1 )

Aurobindo Pharma Limited


4 years ago CAPSULE GREEN E 92 fluoxetine fluoxetine hydrochloride capsule

CAPSULE GREEN E 92

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Fluoxetine capsules USP, 10 mg* are opaque green cap/opaque green body, size ā€˜3ā€™ hard gelatin capsule filled with white to off-white granular powder and imprinted with ā€˜Eā€™ on opaque green cap and ā€˜88ā€™ on opaque green body with black ink. Bottles of 30 NDC 65862-192-30 Bottles of 100 NDC 65862-192-01 Bottles of 500 NDC 65862-192-05 Bottles of 1,000 NDC 65862-192-99 Fluoxetine capsules USP, 20 mg* are opaque green cap/opaque off white body, size ā€˜3ā€™ hard gelatin capsule filled with white to off-white granular powder and imprinted with ā€˜Eā€™ on opaque green cap and ā€˜91ā€™ on opaque off white body with black ink. Bottles of 30 NDC 65862-193-30 Bottles of 100 NDC 65862-193-01 Bottles of 500 NDC 65862-193-05 Bottles of 1,000 NDC 65862-193-99 Fluoxetine capsules USP, 40 mg* are opaque green cap/opaque orange body, size ā€˜2ā€™ hard gelatin capsule filled with white to off-white granular powder and imprinted with ā€˜Eā€™ on opaque green cap and ā€˜92ā€™ on opaque orange body with black ink. Bottles of 30 NDC 65862-194-30 Bottles of 100 NDC 65862-194-01 Bottles of 500 NDC 65862-194-05 Bottles of 1,000 NDC 65862-194-99 *Fluoxetine base equivalent. 16.2 Storage and Handling Store at 20Ā° to 25Ā°C (68Ā° to 77Ā°F); excursions permitted to 15Ā° to 30Ā°C (59Ā° to 86Ā°F) [see USP Controlled Room Temperature]. Preserve in tight, light-resistant containers.


More pills like CAPSULE E 92












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site